Neuralstem to Participate at Cell and Gene Therapy World – GlobeNewswire (press release)
|
Neuralstem to Participate at Cell and Gene Therapy World
GlobeNewswire (press release) GERMANTOWN, Md., Jan. 22, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will discuss … |
